\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\.\\ bp\\ \\=\\ 176\\/100\\.\\ hr\\ \\=\\ 92\\.\\ \ \(0\)\
\-\ exam\\:\\ \ \(30\)\
\-\ skin\\:\\ pink\\,\\ dry\\.\ \(0\)\
\-\ heent\\:\\ perrla\\.\\ otherwise\\ normal\\.\ \(0\)\
\-\ neck\\:\\ non\\-palpable\\ thyroid\\.\ \(0\)\
\-\ remainder\\ of\\ exam\\ noncontributory\\.\ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ urine\\ normetanephrine\\ 24\\ hr\\ \\-\\ 406\\ ug\\/24\\ hrs\\ \\(52\\-310\\)\ \(0\)\
\-\ urine\\ metanephrine\\ 24\\ hr\\ \\-\\ 594\\ ug\\/24\\ hrs\\ \\(95\\-475\\)\ \(0\)\
\-\ surgery\\ is\\ the\\ treatment\\ for\\ pheochromocytoma\\.\ \(0\)\
\-\ 1\\)\\ noncontrast\\ images\\ \\-\\ bilateral\\ adrenal\\ enlargement\\/thickening\\ with\\ distal\\ nodular\\ thickening\\ of\\ the\\ medial\\ branch\\ of\\ the\\ right\\ adrenal\\.\\ hu\\ \\>\\ 10\\ bilaterally\\.\\ homogeneous\\ attenuation\\ with\\ no\\ calcifications\\ bilaterally\\.\ \(0\)\
\-\ 2\\)\\ 50\\ sec\\ post\\ contrast\\ images\\ \\-\\ dense\\ homogeneous\\ enhancement\\ of\\ the\\ bilateral\\ adrenals\\.\\ hu\\ 115\\ left\\ and\\ right\\.\\ \ \(0\)\
\-\ 3\\)\\ 15\\ min\\ post\\ contrast\\ images\\ \\-\\ hu\\ \\@\\ 74\\ bilaterally\\.\\ delayed\\ washout\\ of\\ contrast\\ is\\ demonstrated\\.\\ this\\ is\\ consistent\\ with\\ a\\ non\\-adenomatous\\ process\\.\\ \ \(0\)\
\-\ 4\\)\\ i\\-123\\ mibg\\ 24\\ hr\\ spect\\ image\\,\\ coronal\\ plane\\ \\-\\ bilateral\\ adrenal\\ uptake\\ of\\ mibg\\.\\ \\(confirmed\\ in\\ axial\\ and\\ sagittal\\ planes\\ as\\ right\\ adrenal\\ versus\\ gallbladder\\)\\.\ \(0\)\
\-\ bilateral\\ pheochromocytomas\ \(0\)\
\-\ 1\\)\\ pheochromocytoma\ \(0\)\
\-\ 2\\)\\ adrenal\\ hyperplasia\ \(0\)\
\-\ 3\\)\\ adrenal\\ metastases\ \(0\)\
\-\ 4\\)\\ adrenal\\ carcinoma\ \(0\)\
\-\ 5\\)\\ bilateral\\ adrenal\\ adenomas\ \(0\)\
\-\ 80\\ year\\ old\\ female\\ with\\ severe\\ hypertension\\ non\\-responsive\\ to\\ multiple\\ medication\\ regimens\\.\ \(1\)\
\-\ see\\ factoid\\ with\\ comments\\ tailored\\ to\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.15453150193694137\ \(0\)\
\-\ hr\\:\\ 0\\.07431353703230313\ \(0\)\
\-\ hu\\:\\ 0\\.07392430657985048\ \(0\)\
\-\ ug\\/24\\:\\ 0\\.07252117181612994\ \(0\)\
\-\ mibg\\:\\ 0\\.06271213352445038\ \(0\)\
\-\ hrs\\:\\ 0\\.052903095232770835\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.04928287105323365\ \(0\)\
\-\ \\-\\:\\ 0\\.04906415514397402\ \(0\)\
\-\ bilateral\\:\\ 0\\.04629057431505455\ \(0\)\
\-\ 24\\:\\ 0\\.044497191704811825\ \(0\)\
\-\ \\=\\:\\ 0\\.04004272396143006\ \(0\)\
\-\ 176\\/100\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ 92\\.\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ 52\\-310\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ enlargement\\/thickening\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ non\\-adenomatous\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ pheochromocytomas\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ \\)\\:\\ 0\\.03822523350606991\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03758980230165942\ \(0\)\
\-\ urine\\:\\ 0\\.0368229512655121\ \(0\)\
\-\ 406\\:\\ 0\\.03626058590806497\ \(0\)\
\-\ 594\\:\\ 0\\.03626058590806497\ \(0\)\
\-\ 95\\-475\\:\\ 0\\.03626058590806497\ \(0\)\
\-\ homogeneous\\:\\ 0\\.03611458749554315\ \(0\)\
\-\ normetanephrine\\:\\ 0\\.03316617885199378\ \(0\)\
\-\ non\\-responsive\\:\\ 0\\.03316617885199378\ \(0\)\
\-\ non\\-palpable\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ metanephrine\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ adrenals\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ tailored\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ comments\\:\\ 0\\.03135606676222519\ \(0\)\
\-\ 115\\:\\ 0\\.029545954672456597\ \(0\)\
\-\ regimens\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ min\\:\\ 0\\.02790432618975429\ \(0\)\
\-\ \\@\\:\\ 0\\.02790432618975429\ \(0\)\
\-\ sec\\:\\ 0\\.027573487028353747\ \(0\)\
\-\ i\\-123\\:\\ 0\\.027265483137786997\ \(0\)\
\-\ washout\\:\\ 0\\.026451547616385417\ \(0\)\
\-\ contrast\\:\\ 0\\.02561753151974873\ \(0\)\
\-\ pink\\:\\ 0\\.02535725092873816\ \(0\)\
\-\ spect\\:\\ 0\\.02535725092873816\ \(0\)\
\-\ adenomas\\:\\ 0\\.02535725092873816\ \(0\)\
\-\ \\:\\:\\ 0\\.025229348571220202\ \(0\)\
\-\ perrla\\:\\ 0\\.024641435526616826\ \(0\)\
\-\ post\\:\\ 0\\.024025312795288335\ \(0\)\
\-\ dry\\:\\ 0\\.02266896788251397\ \(0\)\
\-\ images\\:\\ 0\\.021954427124321704\ \(0\)\
\-\ planes\\:\\ 0\\.02189060454704621\ \(0\)\
\-\ 74\\:\\ 0\\.021802199960902553\ \(0\)\
\-\ plane\\:\\ 0\\.021305656947017623\ \(0\)\
\-\ 4\\:\\ 0\\.021258677724812904\ \(0\)\
\-\ branch\\:\\ 0\\.02065117715151818\ \(0\)\
\-\ noncontrast\\:\\ 0\\.02038849634784437\ \(0\)\
\-\ medication\\:\\ 0\\.019217227310043074\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.01879619749097503\ \(0\)\
\-\ heent\\:\\ 0\\.018452621414474457\ \(0\)\
\-\ gallbladder\\:\\ 0\\.018330304565420376\ \(0\)\
\-\ noncontributory\\:\\ 0\\.01829026586014019\ \(0\)\
\-\ 1\\:\\ 0\\.018154699713925953\ \(0\)\
\-\ versus\\:\\ 0\\.01813360818241131\ \(0\)\
\-\ dense\\:\\ 0\\.01801962022703111\ \(0\)\
\-\ remainder\\:\\ 0\\.01798226196957345\ \(0\)\
\-\ 80\\:\\ 0\\.01794521374272213\ \(0\)\
\-\ 3\\:\\ 0\\.017865852917022675\ \(0\)\
\-\ afebrile\\:\\ 0\\.01762492845317373\ \(0\)\
\-\ exam\\:\\ 0\\.016761017320978018\ \(0\)\
\-\ bp\\:\\ 0\\.01656059352707999\ \(0\)\
\-\ 2\\:\\ 0\\.016429504433129877\ \(0\)\
\-\ metastases\\:\\ 0\\.01629791272340618\ \(0\)\
\-\ nodular\\:\\ 0\\.01600182949603532\ \(0\)\
\-\ coronal\\:\\ 0\\.01588403148186927\ \(0\)\
\-\ thyroid\\:\\ 0\\.01563532341484246\ \(0\)\
\-\ delayed\\:\\ 0\\.015526697965469552\ \(0\)\
\-\ attenuation\\:\\ 0\\.015337594064401957\ \(0\)\
\-\ 15\\:\\ 0\\.015215833270117765\ \(0\)\
\-\ sagittal\\:\\ 0\\.015215833270117765\ \(0\)\
\-\ uptake\\:\\ 0\\.01515617600309916\ \(0\)\
\-\ hypertension\\:\\ 0\\.015039201126340124\ \(0\)\
\-\ process\\:\\ 0\\.014687792343012117\ \(0\)\
\-\ skin\\:\\ 0\\.014652361318031151\ \(0\)\
\-\ 50\\:\\ 0\\.014513384002874127\ \(0\)\
\-\ confirmed\\:\\ 0\\.014345533942351774\ \(0\)\
\-\ calcifications\\:\\ 0\\.014183766761753359\ \(0\)\
\-\ otherwise\\:\\ 0\\.013702300149224753\ \(0\)\
\-\ factoid\\:\\ 0\\.013372479882205968\ \(0\)\
\-\ labs\\:\\ 0\\.013267741102389008\ \(0\)\
\-\ thickening\\:\\ 0\\.012931359686131034\ \(0\)\
\-\ 10\\:\\ 0\\.01285992959083442\ \(0\)\
\-\ \\>\\:\\ 0\\.012674854976198947\ \(0\)\
\-\ medial\\:\\ 0\\.012202229971384159\ \(0\)\
\-\ right\\:\\ 0\\.012075424675585937\ \(0\)\
\-\ image\\:\\ 0\\.011916023063828574\ \(0\)\
\-\ severe\\:\\ 0\\.011737990178866089\ \(0\)\
\-\ see\\:\\ 0\\.011384898264414233\ \(0\)\
\-\ neck\\:\\ 0\\.011201978290261082\ \(0\)\
\-\ demonstrated\\:\\ 0\\.011193839207397175\ \(0\)\
\-\ 5\\:\\ 0\\.011161430457340015\ \(0\)\
\-\ axial\\:\\ 0\\.01088746194673157\ \(0\)\
\-\ carcinoma\\:\\ 0\\.010812177098285117\ \(0\)\
\-\ distal\\:\\ 0\\.010371779414937618\ \(0\)\
\-\ enhancement\\:\\ 0\\.01022539627733498\ \(0\)\
\-\ \\(\\:\\ 0\\.009674487405051703\ \(0\)\
\-\ consistent\\:\\ 0\\.009354010128710727\ \(0\)\
\-\ surgery\\:\\ 0\\.009263388680179799\ \(0\)\
\-\ this\\:\\ 0\\.00858158226173333\ \(0\)\
\-\ case\\:\\ 0\\.008346001932443172\ \(0\)\
\-\ multiple\\:\\ 0\\.008034848229818163\ \(0\)\
\-\ female\\:\\ 0\\.007842679783249257\ \(0\)\
\-\ treatment\\:\\ 0\\.007721504283932531\ \(0\)\
\-\ is\\:\\ 0\\.007530680067652575\ \(0\)\
\-\ normal\\:\\ 0\\.005980412743745987\ \(0\)\
\-\ as\\:\\ 0\\.005770435294170213\ \(0\)\
\-\ left\\:\\ 0\\.004268327094968369\ \(0\)\
\-\ year\\:\\ 0\\.004268327094968369\ \(0\)\
\-\ old\\:\\ 0\\.0039059580217064935\ \(0\)\
\-\ no\\:\\ 0\\.0038412685299276873\ \(0\)\
\-\ to\\:\\ 0\\.0038131081110980916\ \(0\)\
\-\ for\\:\\ 0\\.003254947092154978\ \(0\)\
\-\ \\.\\:\\ 0\\.00316960143726306\ \(0\)\
\-\ of\\:\\ 0\\.00312063752137469\ \(0\)\
\-\ with\\:\\ 0\\.0026117003591493246\ \(0\)\
\-\ the\\:\\ 0\\.0024687372268504607\ \(0\)\
\-\ \\,\\:\\ 0\\.0024170541564043514\ \(0\)\
\-\ in\\:\\ 0\\.0018812376345547094\ \(0\)\
\-\ a\\:\\ 0\\.001770534829547327\ \(0\)\
\-\ and\\:\\ 0\\.001607223265466236\ \(0\)\
